aTYR PHARMA INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
aTYR PHARMA INC quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • aTYR PHARMA INC Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $5.94M, a 16.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $5.94M -$1.18M -16.5% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $6M -$943K -13.6% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $6.73M -$523K -7.21% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $6.81M -$159K -2.28% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $7.12M +$6.29M +761% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $6.94M +$5.89M +561% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $7.25M +$5.98M +472% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $6.97M +$5.49M +371% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $827K -$858K -50.9% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $1.05M -$836K -44.3% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $1.27M -$816K -39.2% Dec 31, 2021 10-K 2023-03-14
Q3 2021 $1.48M -$795K -35% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $1.69M -$776K -31.5% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $1.89M -$757K -28.6% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $2.08M -$738K -26.2% Dec 31, 2020 10-K 2022-03-15
Q3 2020 $2.27M -$720K -24% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $2.46M -$703K -22.2% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $2.64M -$680K -20.5% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $2.82M -$679K -19.4% Dec 31, 2019 10-K 2021-03-24
Q3 2019 $2.99M Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $3.16M Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $3.32M Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $3.5M Jan 1, 2019 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.